Compare Enbridge Inc (ENB) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enbridge Inc vs Teladoc Health Inc — how do they compare? Enbridge Inc trades at $56.26 (market cap $121.39B), while Teladoc Health Inc trades at $9.72 (market cap $1.75B). The key difference: Enbridge Inc is far larger — about 69.4× Teladoc Health Inc's market cap, and Enbridge Inc pays a 5.01% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| ENB | TDOC | |
|---|---|---|
Market Cap | $121.39B | $1.75B |
Sector | Energy | Health |
52-Week High | $58.04 | $9.72 |
52-Week Low | $44.59 | $4.47 |
Enterprise Value | $202.19B | $2.04B |
Dividend Yield | 5.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enbridge (ENB) trades at $55.89, up 1.49% recently, with technical indicators showing a bullish trend. The company reported strong Q1 2026 earnings, beating estimates with $0.71 EPS, and maintains a robust dividend. Revenue grew to $65.19B in 2025, with net income of $7.49B, though valuation ratios like a P/E of 27.02 appear elevated relative to historical norms. Analyst sentiment is mixed with a 48% buy rating, while recent news highlights the company's $28B growth project pipeline and its positioning as a defensive, high-yield stock amid market volatility.
The outlook for ENB is balanced: growth projects and consistent cash flow support dividend sustainability, offering a defensive yield in uncertain markets. However, risks include high leverage, sensitivity to interest rates, and execution challenges on capital projects. The stock's current valuation may limit near-term upside, making it more suitable for income-focused investors rather than those seeking rapid growth.
TDOC trades at $9.27, down 3.94% on the day, with a bullish technical signal from moving averages. The company reported revenue of $2.53B in 2025 but posted a net loss of $200.32M. Recent news highlights the Walmart partnership expansion and upcoming Q2 2026 earnings. Analyst consensus is mixed with 35.71% buy ratings but a price target below current levels at $8.75.
The outlook remains cautious due to persistent losses despite revenue stability. Investment opportunity exists if cost controls and partnerships drive profitability. Key risks include competitive pressures, weak BetterHelp segment, and negative cash flow trends. The stock faces headwinds until sustainable earnings improvement is demonstrated.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
